DAIHAN Scientific Co. Ltd (131220) — Cash Flow Quality Index
DAIHAN Scientific Co. Ltd (131220) has a Cash Flow Quality Index of 0.21x as of September 2025. Operating cash flow of ₩361.12 Million is below net income of ₩1.69 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore DAIHAN Scientific Co. Ltd (131220) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DAIHAN Scientific Co. Ltd Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for DAIHAN Scientific Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 131220 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for DAIHAN Scientific Co. Ltd (2012–2024)
Year-by-year earnings quality comparison for DAIHAN Scientific Co. Ltd. For live market cap and the full company financial profile, see DAIHAN Scientific Co. Ltd (131220) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.02x | ₩3.99 Billion | ₩3.93 Billion | ▲ +10.7% |
| 2023 | 0.92x | ₩4.79 Billion | ₩5.22 Billion | ▼ -4.4% |
| 2022 | 0.96x | ₩4.51 Billion | ₩4.70 Billion | ▼ -12.5% |
| 2021 | 1.10x | ₩4.13 Billion | ₩3.77 Billion | ▼ -64.9% |
| 2020 | 3.13x | ₩5.35 Billion | ₩1.71 Billion | ▲ +57.3% |
| 2019 | 1.99x | ₩2.44 Billion | ₩1.23 Billion | ▼ -5.5% |
| 2018 | 2.10x | ₩3.76 Billion | ₩1.79 Billion | ▼ -53.3% |
| 2017 | 4.50x | ₩4.58 Billion | ₩1.02 Billion | ▲ +99.1% |
| 2016 | 2.26x | ₩4.12 Billion | ₩1.82 Billion | ▼ -23.5% |
| 2014 | 2.96x | ₩2.59 Billion | ₩875.88 Million | ▲ +553.5% |
| 2012 | 0.45x | ₩565.94 Million | ₩1.25 Billion | — |